|
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results |
|
|
|
Title: |
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results |
Author: |
Gener-Ricos, Georgina Haddad, Fadi G. Sasaki, Koji Issa, Ghayas C. Skinner, Jeffrey Masarova, Lucia Borthakur, Gautam Alvarado, Yesid Garcia-Manero, Guillermo Jabbour, Elias Kantarjian, Hagop |
Appeared in: |
Clinical lymphoma myeloma and leukemia |
Paging: |
Volume 23 () nr. 10 pages 742-748 |
Year: |
2023 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|